{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:54:27Z","timestamp":1782874467936,"version":"3.54.5"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2021,1,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Diabetic Ketoacidosis (DKA) is one of the most commonly encountered\ndiabetic complication emergencies. It typically affects people with type 1 diabetes at the onset of\nthe disease. It can also affect people with type 2 diabetes, although this is uncommon.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Research and online content related to diabetes online activity is reviewed. DKA is\ncaused by a relative or absolute deficiency of insulin and elevated levels of counter-regulatory hormones.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Goals of therapy are to correct dehydration, acidosis, and to reverse ketosis, gradually restoring\nblood glucose concentration to near normal.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>It is essential to monitor potential complications of DKA and, if necessary, to treat\nthem and any precipitating events.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574887115666200709172402","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T05:18:00Z","timestamp":1594358280000},"page":"278-288","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An Approach to Diabetic Ketoacidosis in an Emergency Setting"],"prefix":"10.2174","volume":"15","author":[{"given":"Dario","family":"Pitocco","sequence":"first","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Di Leo","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Tartaglione","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele Gaetano","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Caputo","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rizzi","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","volume":"12","author":"Umpierrez G.","year":"2016","unstructured":"Umpierrez G.; Korytkowski M.; Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 2016,12(4),222-232","journal-title":"Nat Rev Endocrinol"},{"key":"ref=2","first-page":"337","volume":"87","author":"Westerberg D.P.","year":"2013","unstructured":"Westerberg D.P.; Diabetic ketoacidosis: Evaluation and treatment. Am Fam Physician 2013,87(5),337-346","journal-title":"Am Fam Physician"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1056\/NEJMc1701990","volume":"376","author":"Fralick M.","year":"2017","unstructured":"Fralick M.; Schneeweiss S.; Patorno E.; Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibi-tor. N Engl J Med 2017,376(23),2300-2302","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1007\/s00125-012-2690-2","volume":"55","author":"Usher-Smith J.A.","year":"2012","unstructured":"Usher-Smith J.A.; Thompson M.; Ercole A.; Walter F.M.; Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: A systematic review. Diabetologia 2012,55(11),2878-2894","journal-title":"Diabetologia"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e016587","DOI":"10.1136\/bmjopen-2017-016587","volume":"7","author":"Fazeli Farsani S.","year":"2017","unstructured":"Fazeli Farsani S.; Brodovicz K.; Soleymanlou N.; Marquard J.; Wissinger E.; Maiese B.A.; Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): A systematic literature review. BMJ Open 2017,7(7),e016587","journal-title":"BMJ Open"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.metabol.2015.12.007","volume":"65","author":"Nyenwe E.A.","year":"2016","unstructured":"Nyenwe E.A.; Kitabchi A.E.; The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism 2016,65(4),507-521","journal-title":"Metabolism"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/qjmed\/hcr226","volume":"105","author":"Van Zyl D.G.","year":"2012","unstructured":"Van Zyl D.G.; Rheeder P.; Delport E.; Fluid management in diabetic-acidosis--Ringer\u2019s lactate versus normal saline: A randomized controlled trial. QJM 2012,105(4),337-343","journal-title":"QJM"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"CD000567","DOI":"10.1002\/14651858.CD000567.pub6","volume":"2","author":"Perel P.","year":"2013","unstructured":"Perel P.; Roberts I.; Ker K.; Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013,2(2),CD000567","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fendo.2017.00106","volume":"8","author":"Tran T.T.T.","year":"2017","unstructured":"Tran T.T.T.; Pease A.; Wood A.J.; Zajac J.D.; M\u00e5rtensson J.; Bellomo R.; Ekinci E.I.I.; Review of Evidence for adult diabetic ketoacidosis management protocols. Front Endocrinol (Lausanne) 2017,8,106","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"CD011281","DOI":"10.1002\/14651858.CD011281.pub2","volume":"1","author":"Andrade-Castellanos C.A.","year":"2016","unstructured":"Andrade-Castellanos C.A.; Colunga-Lozano L.E.; Delgado-Figueroa N.; Gonzalez-Padilla D.A.; Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev 2016,1(1),CD011281","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.amjmed.2004.05.010","volume":"117","author":"Umpierrez G.E.","year":"2004","unstructured":"Umpierrez G.E.; Latif K.; Stoever J.; Cuervo R.; Park L.; Freire A.X.; E Kitabchi A.; Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 2004,117(5),291-296","journal-title":"Am J Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1368-5031.2006.00786.x","volume":"60","author":"Ers\u00f6z H.O.","year":"2006","unstructured":"Ers\u00f6z H.O.; Ukinc K.; K\u00f6se M.; Erem C.; Gunduz A.; Hacihasanoglu A.B.; Karti S.S.; Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract 2006,60(4),429-433","journal-title":"Int J Clin Pract"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4239\/wjd.v9.i12.226","volume":"9","author":"Islam T.","year":"2018","unstructured":"Islam T.; Sherani K.; Surani S.; Vakil A.; Guidelines and controversies in the management of diabetic ketoacidosis - A mini-review. World J Diabetes 2018,9(12),226-229","journal-title":"World J Diabetes"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jemermed.2007.11.033","volume":"38","author":"Goyal N.","year":"2010","unstructured":"Goyal N.; Miller J.B.; Sankey S.S.; Mossallam U.; Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. J Emerg Med 2010,38(4),422-427","journal-title":"J Emerg Med"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"e000395","DOI":"10.1136\/bmjdrc-2017-000395","volume":"5","year":"2017","unstructured":"Comparison of a \u2018two-bag system\u2019 versus conventional treatment protocol (\u2018one-bag system\u2019) in the management of diabetic ketoacidosis BMJ Open Diabetes Res Care Munir A, Fargo I, Garrison R, et al2017,5,e000395","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.2337\/dc06-9909","volume":"29","author":"Wolfsdorf J.","year":"2006","unstructured":"Wolfsdorf J.; Glaser N.; Sperling M.A.; Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care American Diabetes Association2006,29(5),1150-1159","journal-title":"Diabetes Care"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2337\/dc15-0843","volume":"38","author":"Peters A.L.","year":"2015","unstructured":"Peters A.L.; Buschur E.O.; Buse J.B.; Cohan P.; Diner J.C.; Hirsch I.B.; Euglycemic diabetic ketoacidosis: A po-tential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care 2015,38(9),1687-1693","journal-title":"Diabetes Care"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1542\/peds.2013-2795","volume":"133","author":"Dabelea D.","year":"2014","unstructured":"Dabelea D.; Rewers A.; Stafford J.M.; Standiford D.A.; Lawrence J.M.; Saydah S.; Imperatore G.; D\u2019Agostino R.B.; Mayer-Davis E.J.; Pihoker C.; Trends in the prevalence of ketoacidosis at diabetes diagnosis: The SEARCH for diabetes in youth study. Pediatrics SEARCH for Diabetes in Youth Study Group2014,133(4),e938-e945","journal-title":"Pediatrics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2337\/diab.20.4.228","volume":"20","author":"Gerich J.E.","year":"1971","unstructured":"Gerich J.E.; Martin M.M.; Recant L.; Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes 1971,20(4),228-238","journal-title":"Diabetes"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.schres.2014.01.043","volume":"154","author":"Lipscombe L.L.","year":"2014","unstructured":"Lipscombe L.L.; Austin P.C.; Alessi-Severini S.; Blackburn D.F.; Blais L.; Bresee L.; Filion K.B.; Kawasumi Y.; Kurdyak P.; Platt R.W.; Tamim H.; Paterson J.M.; Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data. Schizophr Res Canadian Network for Observational Drug Effect Studies (CNODES) Investigators2014,154(1-3),54-60","journal-title":"Schizophr Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00024677-200302020-00003","volume":"2","author":"Umpierrez G.E.","year":"2003","unstructured":"Umpierrez G.E.; Kitabchi A.E.; Diabetic ketoacidosis: Risk factors and management strategies. Treat Endocrinol 2003,2(2),95-108","journal-title":"Treat Endocrinol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1001\/jama.1984.03350230025026","volume":"252","author":"Mecklenburg R.S.","year":"1984","unstructured":"Mecklenburg R.S.; Benson E.A.; Benson J.W.; Fredlund P.N.; Guinn T.; Metz R.J.; Nielsen R.L.; Sanner C.A.; Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 1984,252(23),3265-3269","journal-title":"JAMA"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1573399812666160421121307","volume":"13","author":"Modi A.","year":"2017","unstructured":"Modi A.; Agrawal A.; Morgan F.; Euglycemic diabetic ketoacidosis: A review. Curr Diabetes Rev 2017,13(3),315-321","journal-title":"Curr Diabetes Rev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/dom.13012","volume":"20","author":"Bonora B.M.","year":"2018","unstructured":"Bonora B.M.; Avogaro A.; Fadini G.P.; Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature. Diabetes Obes Metab 2018,20(1),25-33","journal-title":"Diabetes Obes Metab"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJM200101253440404","volume":"344","author":"Glaser N","year":"2001","unstructured":"Glaser N; Barnett P; McCaslin I; Risk factors for cerebral edema in children with diabetic ketoacidosis N Engl J Med 2001,344,264-9","journal-title":"N Engl J Med"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1399-543X.2006.00156.x","volume":"7","author":"Glaser NS","year":"2006","unstructured":"Glaser NS; Frequency of subclinical cerebral edema in children with diabetic ketoacidosis Pediatr Diabetes 2006,7,75-80","journal-title":"Pediatr Diabetes"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/GRF.0b013e31815a5494","volume":"50","author":"Lain K.Y.","year":"2007","unstructured":"Lain K.Y.; Catalano P.M.; Metabolic changes in pregnancy. Clin Obstet Gynecol 2007,50(4),938-948","journal-title":"Clin Obstet Gynecol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.2337\/dc17-0186","volume":"40","author":"Morrison F.J.R.","year":"2017","unstructured":"Morrison F.J.R.; Movassaghian M.; Seely E.W.; Curran A.; Shubina M.; Morton-Eggleston E.; Zera C.A.; Ecker J.L.; Brown F.M.; Turchin A.; Fetal outcomes after diabetic ketoacidosis during preg-nancy. Diabetes Care 2017,40(7),e77-e79","journal-title":"Diabetes Care"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","volume":"371","author":"Goldenberg R.L.","year":"2008","unstructured":"Goldenberg R.L.; Culhane J.F.; Iams J.D.; Romero R.; Epidemiology and causes of preterm birth. Lancet 2008,371(9606),75-84","journal-title":"Lancet"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000013607","volume":"20","author":"Gokel Y.","year":"2000","unstructured":"Gokel Y.; Paydas S.; Koseoglu Z.; Alparslan N.; Seydaoglu G.; Comparison of blood gas and acid-base measurements in arterial and venous blood samples in patients with uremic acidosis and diabetic ketoacidosis in the emergency room. Am J Nephrol 2000,20(4),319-323","journal-title":"Am J Nephrol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1197\/aemj.10.8.836","volume":"10","author":"Ma O.J.","year":"2003","unstructured":"Ma O.J.; Rush M.D.; Godfrey M.M.; Gaddis G.; Arterial blood gas results rarely influence emergency physician management of patients with suspected diabetic ketoacidosis. Acad Emerg Med 2003,10(8),836-841","journal-title":"Acad Emerg Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/dme.12604","volume":"32","author":"Misra S.","year":"2015","unstructured":"Misra S.; Oliver N.S.; Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabet Med 2015,32(1),14-23","journal-title":"Diabet Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/adc.2003.044875","volume":"89","author":"Dunger D.B.","year":"2004","unstructured":"Dunger D.B.; Sperling M.A.; Acerini C.L.; Bohn D.J.; Daneman D.; Danne T.P.; Glaser N.S.; Hanas R.; Hintz R.L.; Levitsky L.L.; Savage M.O.; Tasker R.C.; Wolfsdorf J.I.; ESPE\/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child ESPE2004,89(2),188-194","journal-title":"Arch Dis Child"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMoa1716816","volume":"378","author":"Kuppermann N.","year":"2018","unstructured":"Kuppermann N.; Ghetti S.; Schunk J.E.; Stoner M.J.; Rewers A.; McManemy J.K.; Myers S.R.; Nigrovic L.E.; Garro A.; Brown K.M.; Quayle K.S.; Trainor J.L.; Tzimenatos L.; Bennett J.E.; DePiero A.D.; Kwok M.Y.; Perry C.S.; Olsen C.S.; Casper T.C.; Dean J.M.; Glaser N.S.; Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med PECARN DKA FLUID Study Group2018,378(24),2275-2287","journal-title":"N Engl J Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1399-5448.2009.00536.x","volume":"11","author":"Puttha R.","year":"2010","unstructured":"Puttha R.; Cooke D.; Subbarayan A.; Odeka E.; Ariyawansa I.; Bone M.; Doughty I.; Patel L.; Amin R.; Low dose (0.05 units\/kg\/h) is comparable with standard dose (0.1 units\/kg\/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study. Pediatr Diabetes North West England Paediatric Diabetes Network2010,11(1),12-17","journal-title":"Pediatr Diabetes"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2337\/diacare.13.1.22","volume":"13","author":"Rosenbloom A.L.","year":"1990","unstructured":"Rosenbloom A.L.; Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990,13(1),22-33","journal-title":"Diabetes Care"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/BF00263548","volume":"13","author":"Hillman K.","year":"1987","unstructured":"Hillman K.; Fluid resuscitation in diabetic emergencies-a reappraisal. Intensive Care Med 1987,13(1),4-8","journal-title":"Intensive Care Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1399-5448.2009.00511.x","volume":"10","author":"Glaser N.","year":"2009","unstructured":"Glaser N.; Cerebral injury and cerebral edema in children with diabetic ketoacidosis: Could cerebral ischemia and reperfusion injury be involved? Pediatr Diabetes 2009,10(8),534-541","journal-title":"Pediatr Diabetes"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.2337\/db07-1410","volume":"57","author":"Yuen N.","year":"2008","unstructured":"Yuen N.; Anderson S.E.; Glaser N.; Tancredi D.J.; O\u2019Donnell M.E.; Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes 2008,57(10),2588-2594","journal-title":"Diabetes"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1034\/j.1399-5448.2001.002003109.x","volume":"2","author":"Roberts M.D.","year":"2001","unstructured":"Roberts M.D.; Slover R.H.; Chase H.P.; Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes 2001,2(3),109-114","journal-title":"Pediatr Diabetes"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2337\/diaclin.32.1.28","volume":"32","author":"Regmi A.","year":"2014","unstructured":"Regmi A.; Konstantinov N.K.; Agaba E.I.; Rohrscheib M.; Dorin R.I.; Tzamaloukas A.H.; Respiratory failure in the course of treatment of diabetic ketoacidosis. Clin Diabetes 2014,32(1),28-31","journal-title":"Clin Diabetes"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.2337\/dc09-0169","volume":"32","author":"Umpierrez G.E.","year":"2009","unstructured":"Umpierrez G.E.; Jones S.; Smiley D.; Mulligan P.; Keyler T.; Temponi A.; Semakula C.; Umpierrez D.; Peng L.; Cer\u00f3n M.; Robalino G.; Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care 2009,32(7),1164-1169","journal-title":"Diabetes Care"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1464-5491.2011.03246.x","volume":"28","author":"Savage M.W.","year":"2011","unstructured":"Savage M.W.; Dhatariya K.K.; Kilvert A.; Rayman G.; Rees J.A.; Courtney C.H.; Hilton L.; Dyer P.H.; Hamersley M.S.; Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med Joint British Diabetes Societies2011,28(5),508-515","journal-title":"Diabet Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.15585\/mmwr.mm6712a3","volume":"67","author":"Benoit S.R.","year":"2018","unstructured":"Benoit S.R.; Zhang Y.; Geiss L.S.; Gregg E.W.; Albright A.; Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality-United States, 2000-2014. MMWR Morb Mortal Wkly Rep 2018,67(12),362-365","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1111\/dom.13811","volume":"21","author":"Goldenberg R.M.","year":"2019","unstructured":"Goldenberg R.M.; Gilbert J.D.; Hramiak I.M.; Woo V.C.; Zinman B.; Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol. Diabetes Obes Metab 2019,21(10),2192-2202","journal-title":"Diabetes Obes Metab"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4158\/EP161292.PS","author":"Handelsman Y","year":"2016","unstructured":"Handelsman Y; Henry RR; Bloomgarden ZT;  Endocr Pract American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis2016,753-62","journal-title":"Endocr Pract"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/pedi.12741","volume":"19","author":"Laffel L.M.","year":"2018","unstructured":"Laffel L.M.; Limbert C.; Phelan H.; Virmani A.; Wood J.; Hofer S.E.; ISPAD Clinical Practice Consensus Guidelines 2018: Sick day management in children and adolescents with diabetes. Pediatr Diabetes 2018,19(Suppl. 27),193-204","journal-title":"Pediatr Diabetes"},{"key":"ref=48","author":"Ness K.","year":"2013","unstructured":"Ness K.; Hrachovec J.B.; Klee K.; Leu M.G.; Magin J.;  Insulin Sick Day Management for Diabetes (Non-DKA) Pathway Seattle Children\u2019s Hospital2013","journal-title":"Insulin Sick Day Management for Diabetes (Non-DKA) Pathway"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1056\/NEJMoa1708337","volume":"377","author":"Garg S.K.","year":"2017","unstructured":"Garg S.K.; Henry R.R.; Banks P.; Buse J.B.; Davies M.J.; Fulcher G.R.; Pozzilli P.; Gesty-Palmer D.; Lapuerta P.; Sim\u00f3 R.; Danne T.; McGuire D.K.; Kushner J.A.; Peters A.; Strumph P.; Effects of sotagliflozin added to insulin in patients with Type 1 Diabetes. N Engl J Med 2017,377(24),2337-2348","journal-title":"N Engl J Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"l1328","DOI":"10.1136\/bmj.l1328","volume":"365","author":"Musso G.","year":"2019","unstructured":"Musso G.; Gambino R.; Cassader M.; Paschetta E.; Efficacy and safety of dual SGLT 1\/2 inhibitor sotagliflozin in type 1 diabetes: Meta-analysis of randomised controlled trials. BMJ 2019,365,l1328","journal-title":"BMJ"}],"container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183602","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183602\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T05:52:38Z","timestamp":1628056358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183602\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,1,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574887115666200709172402","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}